The basis of the ␤-lactam resistance of 39 multidrug-resistant Acinetobacter baumannii isolates recovered from hospitalized patients was studied. These isolates were collected from 2001 to 2005 at the Sahloul Hospital in Sousse, Tunisia. They belonged to two distinct clones. One clone that grouped 19 isolates produced a carbapenem-hydrolyzing oxacillinase, OXA-97, that differed from OXA-58 by a single amino acid substitution and conferred the same ␤-lactam resistance profile as OXA-58. The bla OXA-97 gene was located on plasmids that varied in size in 18 isolates and was chromosomally located in a single isolate. Cloning and sequencing identified genetic structures surrounding the bla OXA-97 gene similar to those reported to be adjacent to the bla OXA-58 gene. In addition, the novel ISAba8 element (which is of the IS21 family) was identified. This is the first report of the nosocomial spread of carbapenemase producers in A. baumannii isolates in Africa.
formed with bla OXA-69 -specific primers on one side and ISAba1-specific primers on the other side (2, 30) . Sequencing reactions were performed with an automated sequencer (ABI 3130; Applied Biosystems, Foster City, CA). The nucleotide and deduced protein sequences were analyzed with software available over the Internet (http://www.ncbi.nlm.hih.gov).
Cloning experiments and analysis of recombinant plasmids. Cloning into E. coli TOP10 was performed as described previously (19) by using EcoRI-digested whole-cell DNA of bla OXA-97 -positive A. baumannii strain A10 ligated into EcoRI-restricted plasmid pBK-CMV (Stratagene, La Jolla, CA), followed by selection on plates containing 50 g/ml of amoxicillin and 30 g/ml of kanamycin.
In addition, PCR amplicons encompassing the entire sequence of the bla OXA-97 gene and bla were obtained with primers pre-OXA-58 promϩ and pre-OXA-58B (22) from whole-cell DNA of A. baumannii isolates A1 and MAD, respectively, and were subsequently cloned by use of a ZeroBlunt TOPO PCR cloning kit (Invitrogen, Cergy-Pontoise, France). Recombinant strains E. coli TOP10(pOXA-97) and E. coli TOP10(pOXA-58) were used for MIC and specific activity comparisons (24) .
PFGE and Southern hybridization. Pulsed-field gel electrophoresis (PFGE) analysis was done, and the results were interpreted as described previously (18, 29) . DNA-DNA hybridizations were performed as described by Sambrook et al. (26) with a probe consisting of a 528-bp PCR fragment internal to bla OXA-97 generated from A. baumannii A1 (24) . Labeling of the probe and signal detection were carried out with a nonradioactive enhanced chemiluminescence labeling and detection kit according to the manufacturer's instructions (Amersham Pharmacia Biotech).
Transformation and plasmid DNA content analysis. Transformation experiments were performed with clinical isolates A. baumannii A1 and A. baumannii A2 as plasmid donors and A. baumannii CIP7010 as the recipient strain (14) . Transformants were selected on Trypticase soy agar plates containing 50 g/ml of ticarcillin.
To assess the chromosomal location of the ␤-lactamase gene, we used the homing endonuclease I-CeuI (Ozyme; New England Biolabs) (15) and separated the fragments by PFGE, as reported previously (18) . After transfer onto a nylon membrane, the DNA was UV cross-linked (Stratalinker; Stratagene) and hybridized with two different probes: a 1,504-bp PCR-generated probe specific for the 16S and 23S rRNA genes (18) and a 528-bp probe specific for bla OXA-97 , as indicated above.
Measurement of ␤-lactamase specific activities. Crude cell extracts were obtained by sonication from A. baumannii clinical isolates and E. coli TOP10 recombinant strains expressing ␤-lactamases OXA-97 and OXA-58, respectively, as described previously (13, 20) . The ␤-lactamase specific activities were determined for imipenem, meropenem, cephalothin, ceftazidime, oxacillin, and benzylpenicillin, which were each used at a final concentration of 100 M, as described previously (13) .
Nucleotide sequence accession number. The nucleotide sequence data reported in this work have been deposited in the GenBank nucleotide database under accession no. EF102240. . These isolates had been recovered from different specimens (mostly blood cultures and pus) of patients hospitalized in five wards. Two main antibiotic resistance phenotypes were observed. Nineteen isolates (isolates A1 to A19) exhibited phenotype I (resistance to all ␤-lactams, including carbapenems, fluoroquinolones, tigecycline, and gentamicin, and susceptibility to tobramycin and colistin). Twenty isolates exhibited phenotype II (resistance to ceftazidime, carbapenems, and fluoroquinolones; intermediate susceptibility to ticarcillin, cefepime, and tigecycline; and susceptibility to gentamicin, tobramycin, and colistin). PFGE analysis showed that the 19 A. baumannii isolates of phenotype I were clonally related, whereas the other carbapenem-resistant isolates (phenotype II) were distinct but clonally related (data not shown). The isolates belonging to phenotype II were recovered in 2004 (3 of 7 isolates) and 2005 (17 of 18 isolates). Hydrolytic assays showed that isolates of phenotype I had weak carbapenemase activities, whereas those of phenotype II did not ( Table 1) .
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Identification of CHDL-encoding A. baumannii isolates. The results obtained with Etest strips combining imipenem and EDTA did not identify MBL production by the phenotype I or II isolates. PCR experiments with primers specific for CHDLencoding genes were performed with all 39 clinical isolates; and bla OXA-58 -like genes were identified only in isolates exhibiting phenotype I, but no bla OXA-23 -or bla OXA-40 -like gene was detected in the whole collection. The carbapenem resistance in the phenotype II isolates was therefore not mediated by ␤-lactamase and may be related to permeability defects and/or the overexpression of efflux. Overall, the isolates positive for the bla OXA-58 -like gene were recovered from multiple wards and were detected during the entire study period.
Sequencing of the bla OXA-58 -positive amplicons obtained from all isolates of phenotype I identified a gene with a single base pair substitution with respect to the sequence of bla OXA-58 . This substitution gave rise to OXA-97 with an Ala-to-Gly substitution at position DBL35 (corresponding to amino acid 53 of the premature OXA-58 sequence) (24) . Cloning experiments were performed in identical plasmid and strain backgrounds to compare the OXA-97 and the OXA-58 hydrolysis spectra toward ␤-lactams. Analysis of the MICs of ␤-lactams and measurement of the specific activities with imipenem and benzylpenicillin as the substrates showed very similar results for both recombinant strains, E. coli DH10B(pOXA-97) and E. coli DH10B(pOXA-58), suggesting an identical hydrolysis spectrum (Table) .
Screening of the naturally occurring bla OXA-51/OXA-69 gene of A. baumannii was performed with the bla OXA-97 -positive isolates that gave positive results. PCR was also performed to search for the ISAba1 element and gave a positive result for all these isolates, in agreement with previous observations showing the ubiquity of that IS element in A. baumannii (11, 28) . However, PCR experiments did not identify ISAba1 upstream of the bla OXA-97 gene, thus ruling out the ISAba1-mediated overexpression of this naturally occurring CHDL gene.
Genetic location of bla OXA-97 . Plasmid analysis identified two or three plasmids with different sizes in the 19 bla OXA-97 -positive isolates. Hybridization with a bla OXA-97 -specific probe gave a single positive signal, corresponding to a 60-kb plasmid for 12 isolates, a 50-kb plasmid for 4 isolates, and a 45-kb plasmid for 2 isolates; no hybridization signal was obtained for isolate A2. The chromosomal location of the bla OXA-97 gene in isolate A2 was confirmed by use of the I-CeuI technique. Thus, ␤-lactamase OXA-97 was plasmid encoded in all except one of the isolates; in the latter isolate, integration of the bla OXA-97 -positive plasmid or mobilization of this gene from the plasmid to the chromosome may have occurred.
Transfer of the ticarcillin resistance marker was successful by use of all the bla OXA-97 -positive A. baumannii clinical iso-lates as donors (except for isolate A2) and an A. baumannii reference strain as the recipient but not an E. coli strain as the recipient. A. baumannii CIP7010 transformants harboring the bla OXA-97 -positive natural plasmids exhibited a ␤-lactam resistance pattern consistent with that resulting from the expression of OXA-58/OXA-97, with MICs identical to those already obtained with natural plasmid pMAD (14) . The bla OXA-97 -positive plasmids did not confer additional resistance to antibiotics, except for resistance to tetracycline for plasmids obtained from four isolates.
Genetic structures surrounding the bla OXA-97 gene. Cloning of the EcoRI-restricted DNA of A. baumannii A1 gave rise to recombinant plasmid pA1WM, which expressed the bla OXA-97 gene. Sequencing of the 13,122-bp insert revealed that an ISAba3-like element was located 20 bp upstream of bla OXA-97 , as previously identified in other structures upstream of the bla OXA-58 gene (23, 24) . PCR mapping showed that this ISAba3-like element was not truncated by an IS26, ISAba1, or ISAba2 element, as opposed to what has previously been found (2, 24, 25) . An entire copy of ISAba3 was identified downstream of the bla OXA-97 gene, followed by the araC1 and the lysE genes, as observed in natural plasmid pMAD (25) . A sequence similar to what has been defined as the Re27-2 structure in A. baumannii MAD was identified downstream of the lysE gene (3 nucleotides of those 27 bp). That structure was likely involved in a homologous recombination process at the origin of the acquisition of the bla OXA-58 gene in the latter strain (22) . An araC2-like gene was identified in A. baumannii MAD (Fig. 1) . A gene encoding a putative regulator was found downstream of araC2, followed by an orf corresponding to a putative 160-amino-acid protein and by a gene encoding a putative transposase. The latter gene was truncated by the insertion of a novel IS element named ISAba8 (see below). An operon containing genes involved in macrolide resistance was identified downstream of the putative transposase gene and was identical to that found on pRSB105, a plasmid isolated from sewage water treatment plants (27) . It included a gene encoding a 491-amino-acid efflux protein also identified in E. coli and Citrobacter freundii (GenBank accession numbers AAN87714.1 and ABG33795.1, respectively) and a 294-aminoacid macrolide 2Ј-phosphotransferase. The gene encoding a 203-amino-acid resolvase/site-specific recombinase identified in pRSB105 was also found (Fig. 1) . Overall, the genetic structures surrounding the bla OXA-97 gene were similar to those identified in association with the bla OXA-58 gene in a series of isolates identified from France, Italy, and Greece (2, 22, 23) , indicating that a common structure has been at the origin of the dissemination of the bla OXA-58 and bla OXA-97 genes.
Identification of ISAba8, a novel IS. ISAba8 is 1,867 bp and belongs to the IS21 family (http://www-is.biotoul.fr/). It possesses 27-bp inverted repeats, and its transposition has likely generated the observed 4-bp target site duplication (CCAT in the structure identified). ISAba8 contains two open reading frames (Orf1 and Orf2) encoding proteins of 339 and 257 amino acids, respectively. The deduced amino acid sequences of the Orf1 and Orf2 proteins had 72% and 79% amino acid identities to the transposase subunits of ISPsy4 and ISRso19, respectively.
Conclusion. This work identified carbapenemase-producing A. baumannii isolates as sources of nosocomial infections in Tunisia. An identical OXA-97-producing A. baumannii isolate was identified from 2001 to 2005, indicating its persistence in the hospital and its environment. This novel ␤-lactamase, OXA-97, is the second member of the OXA-58 subgroup of CHDLs, whose production confers the same ␤-lactam resistance profile as OXA-58. This report constitutes the first report of the nosocomial dissemination of a CHDL-producing A. baumannii strain in Africa, after the identification of single OXA-23-producing A. baumannii isolates from Algeria, Libya, and South Africa (6, 28) . The current worldwide emergence of multiresistant A. baumannii isolates is mostly associated with carbapenemase producers. Therefore, such carbapenemases may be considered the main targets in the development of inhibitors. 
